Personalised medicine approach may hold benefit for late-stage cancer patients
22 April 2009
Malini Guha
A personalised medicine approach appeared to benefit some late-stage cancer patients whose tumours were considered refractory to standard therapy in a pilot study highlighted at a special plenary session at the American Association for Cancer Research (AACR) meeting in Denver.
In the 66-patient...
Please Login to read the full article.
22 April 2009
Malini Guha
In the 66-patient...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Vertex's Incivek wins FDA approval for HCV
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- US Capitol Capsule: Obama uses science medal awards to urge US jobs, STEM ed building
- GlycoMimetics makes good with $340m sickle cell drug deal with Pfizer
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
